Karolinska Development AB KDEV

STO: KDEV | ISIN: SE0002190926 27/06/2025

1,032 SEK (+5,31%)

(+5,31%) 27/06/2025

Grafiek Karolinska Development AB

Grafiek Karolinska Development AB

1 dag1d 5,31%
1 week1w 11,93%
1 maand1m 1,18%
3 maanden3m 6,06%
6 maanden6m 3,82%
1 jaar1j -29,80%
5 jaar5j -64,78%

Karolinska Development AB in het nieuws

Toon enkel gratis nieuws

30 juni 2025 · Karolinska Development divests shares in portfolio company OssDsign · Persbericht

27 juni 2025 · Karolinska Development's portfolio company Modus Therapeutics carries out a fully secured rights issue of SEK 28.3 million · Persbericht

4 juni 2025 · Karolinska Development’s portfolio company OssDsign raises approximately SEK 158 million, announces an updated strategy and revises financial targets · Persbericht

26 mei 2025 · Karolinska Development’s portfolio company Umecrine Cognition resumes patient inclusion in its Phase 1b/2a clinical study · Persbericht

15 mei 2025 · Karolinska Development’s Annual General Meeting 2025 · Persbericht

13 mei 2025 · Karolinska Development’s portfolio company OssDsign has treated 10,000 patients with OssDsign Catalyst in the US · Persbericht

7 mei 2025 · Karolinska Development’s portfolio company Umecrine Cognition presents data validating novel clinical scale in PBC at EASL 2025 · Persbericht

5 mei 2025 · Karolinska Development’s portfolio company Umecrine Cognition receives grant from The Michael J. Fox Foundation · Persbericht

30 april 2025 · Karolinska Development portfolio company OssDsign will change CEO during second half of 2025 · Persbericht

30 april 2025 · Interim Report - January-March 2025 · Persbericht

Profiel Karolinska Development AB

CEO: Viktor Drvota

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe